Home › Funds › Boxer Capital Management, LLC › CBIO

Boxer Capital Management, LLC position in CBIO

CRESCENT BIOPHARMA INC. · Health Care

Boxer Capital Management, LLC reported holding 453,686 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q2 2026 13F filing — a position valued at US$8.2M, representing 0.62% of its reported portfolio and ranking #31 among its reported holdings. Boxer Capital Management, LLC has disclosed CBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)453.69K sh
Reported value held$8.17M
Portfolio Weight0.62%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's CBIO position evolved

Boxer Capital Management, LLC first disclosed a stake in CBIO in Q2 2025 at 453,686 shares (US$7.3M). The position peaked in Q1 2026 at 453,686 shares, worth US$8.3M. Across 5 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 453,686 shares valued at US$8.2M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 453.69K $7.32M New
Q3 2025 453.69K $5.39M Hold
Q4 2025 453.69K $5.38M Hold
Q1 2026 453.69K $8.33M Hold
Q2 2026 453.69K $8.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CBIO and 13F data

CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 71 other funds we track also report a position in CBIO — the largest reported positions include BVF INC/IL (US$49.5M), Fairmount Funds Management LLC (US$49.5M), Venrock Adviser, LLC (US$38.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CBIO

All CBIO fund holders →

FAQ

How long has Boxer Capital Management, LLC held CBIO?

Boxer Capital Management, LLC has disclosed CBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Boxer Capital Management, LLC's current position in CBIO?

As of Q2 2026, Boxer Capital Management, LLC holds 453.69K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $8.17M, representing 0.62% of its reported portfolio and ranking #31.

Has Boxer Capital Management, LLC been buying or selling CBIO?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in CBIO. The position peaked in Q1 2026 at 453.69K shares.

Which other funds hold CBIO?

Other major institutional holders of CBIO include BVF INC/IL, Fairmount Funds Management LLC, Venrock Adviser, LLC, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.